Jesse J Swen Selected Research

Jesse J Swen Research Topics

Disease

8	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 10/2015
6	Neoplasms (Cancer) 01/2022 - 01/2016
6	Rheumatoid Arthritis 01/2020 - 01/2013
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
3	Inflammation (Inflammations) 10/2022 - 12/2020
2	COVID-19 01/2022 - 01/2022
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 01/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2019 - 01/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2022
1	Obesity 01/2022
1	Febrile Neutropenia 01/2022
1	Infections 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Adrenocortical Carcinoma 01/2021
1	Hand-Foot Syndrome 01/2020
1	Mucositis 01/2020
1	Confusion (Bewilderment) 01/2020
1	Viremia 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Clear-cell metastatic renal cell carcinoma 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017
1	Carcinogenesis 01/2016
1	Leukopenia 12/2015
1	Hypertension (High Blood Pressure) 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 06/2015
1	Chemical and Drug Induced Liver Injury 01/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2010

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 10/2022 - 01/2020
7	Sunitinib (Sutent)FDA Link 06/2022 - 10/2015
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2013
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2022 - 12/2020
3	Tamoxifen FDA LinkGeneric 01/2021 - 08/2017
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021 - 08/2017
3	Capecitabine (Xeloda)FDA Link 01/2020 - 06/2015
3	Imatinib Mesylate (Gleevec)FDA Link 10/2019 - 01/2017
2	EnzymesIBA 10/2022 - 12/2020
2	Cytochrome P-450 CYP3AIBA 01/2022 - 10/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 01/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	4-hydroxy-N-desmethyltamoxifenIBA 01/2020 - 08/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2018
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 01/2016
2	Adalimumab (Humira)FDA Link 07/2017 - 01/2015
1	Interleukin-1 (Interleukin 1)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	UracilIBA 01/2022
1	CalcineurinIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	InterleukinsIBA 01/2022
1	Mitotane (Lysodren)FDA Link 01/2021
1	Cytochrome P-450 CYP2C19IBA 01/2021
1	Allopurinol (Remid)FDA LinkGeneric 01/2020
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020
1	abacavir (Ziagen)FDA Link 01/2020
1	TegafurIBA 01/2020
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 10/2019
1	Biological ProductsIBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 07/2017
1	Cytochrome P-450 CYP2C8IBA 01/2017
1	Zoledronic Acid (Zometa)FDA Link 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016
1	Insulin-Like PeptidesIBA 01/2016
1	Interleukin-13IBA 12/2015
1	Interleukin-8 (Interleukin 8)IBA 12/2015
1	Genetic Markers (Genetic Marker)IBA 06/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Cytochrome P-450 CYP2C9IBA 11/2010

Therapy/Procedure

6	Therapeutics 10/2022 - 01/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Drug Tapering 10/2019
1	Radiotherapy 11/2018
1	Neoadjuvant Therapy 01/2016
1	Drug Therapy (Chemotherapy) 01/2016